Safety and efficacy of paediatric silicone Ahmed glaucoma valve (AGV) in adult eyes with post-VR surgery glaucoma.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
11
06
2019
accepted:
02
09
2019
revised:
06
08
2019
pubmed:
7
11
2019
medline:
22
6
2021
entrez:
6
11
2019
Statut:
ppublish
Résumé
To compare the safety and efficacy of the FP8 AGV (paediatric) with the standard FP7 AGV in adult post-vitreoretinal (VR) surgery glaucoma. We included 45 consecutive eyes with post-VR surgery glaucoma implanted with either FP8 (n = 28) or FP7 (n = 17) AGV between 2008 and 2016. The data analysed included visual acuity (VA), intraocular pressure (IOP), complications, interventions, and outcomes. Mean age (p = 0.24), mean baseline VA (p = 0.77), preoperative IOP (p = 0.41), number of antiglaucoma medications (p = 0.92), and previous surgeries (p = 0.16) were comparable in the two groups. The number of eyes with previous belt buckle was significantly higher (p < 0.001) in the FP8 group (17/28) compared with the FP7 group (2/17), indicating space constraint and scarred conjunctiva. The median follow-up (25th, 75th percentile) was 14.7 (9.1, 25.3) months in the FP7 and 9.8 (6.4, 34.7) months in the FP8 groups (p = 0.62). Postoperatively, the median VA (p = 0.24), the mean IOP at final follow-up (p = 0.15), and median number of AGM (p = 0.99) were comparable in both the groups. The median percentage drop in IOP (95% confidence interval) with the FP7 implant was 55% (43.70%) and with FP8 implant was 53.8% (25, 73), (p = 0.20). None in the FP7 group failed, while three eyes in the FP8 group failed. During the study period, two eyes in the FP8 group had tube exposure that was surgically managed. None of the eyes had implant exposure or loss of light perception. Use of the paediatric FP8 AGV in adult post-VR surgery glaucoma eyes with severe conjunctival scarring and limited subconjunctival space resulted in reasonable IOP control compared with the standard FP7 AGV implant. There were no eyes with implant extrusion.
Identifiants
pubmed: 31685973
doi: 10.1038/s41433-019-0663-0
pii: 10.1038/s41433-019-0663-0
pmc: PMC7253436
doi:
Substances chimiques
Silicones
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1121-1128Références
Gedde SJ. Management of glaucoma after retinal detachment surgery. Curr Opin Ophthalmol. 2002;13:103–9.
doi: 10.1097/00055735-200204000-00009
Singh D, Chandra A, Sihota R, Kumar S, Gupta V. Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. Retina. 2014;34:123–8.
doi: 10.1097/IAE.0b013e31828fcb2e
Rotchford AP, Jayasawal R, Madhusudhan S, Ho S, King AJ, Vernon SA. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94:1180–3.
doi: 10.1136/bjo.2008.145565
Sivagnanavel V, Ortiz-Hurtado A, Williamson TH. Diode laser trans-scleral cyclophotocoagulation in the management of glaucoma in patients with long-term intravitreal silicone oil. Eye. 2005;19:253–7.
doi: 10.1038/sj.eye.6701492
Ghazi-Nouri SM, Vakalis AN, Bloom PA, Bunce C, Charteris DG. Long-term results of the management of silicone oil-induced raised intraocular pressure by diode laser cycloablation. Eye. 2005;19:765–9.
doi: 10.1038/sj.eye.6701648
Scott IU, Gedde SJ, Budenz DL, Greenfield DS, Flynn HW Jr, Feuer WJ, et al. Baerveldt drainage implants in eyes with a preexisting scleral buckle. Arch Ophthalmol. 2000;118:1509–13.
doi: 10.1001/archopht.118.11.1509
Choudhari NS, George R, Shantha B, Neog A, Tripathi S, Srinivasan B, et al. Ahmed glaucoma valve in eyes with preexisting episcleral encircling element. Indian J Ophthalmol. 2014;62:570–4.
doi: 10.4103/0301-4738.129788
Gupta S, Chaurasia AK, Chawla R, Kapoor KS, Mahalingam K, Swamy DR, et al. Long-term outcomes of glaucoma drainage devices for glaucoma post-vitreoretinal surgery with silicone oil insertion: a prospective evaluation. Graefe’s Arch Clin Exp Ophthalmol. 2016;254:2449–54.
doi: 10.1007/s00417-016-3469-9
Latina MA, Gulati V. A modification of the Ahmed valve for tight places. Ophthalmic Surg, Lasers Imag. 2003;34:396–7.
Law RW, Li RT, Lai JS, Rao SK, Lam DS. Modification of an adult-sized Ahmed glaucoma valve for a small globe. Jpn J Ophthalmol. 2006;50:67–8.
doi: 10.1007/s10384-005-0265-1
Koh KM, Hwang YH, Jung JJ, Sohn YH, Kim HK. Comparison of the outcome of silicone Ahmed glaucoma valve implantation with a surface area between 96 and 184 mm(2) in adult eyes. Korean J Ophthalmol. 2013;27:361–7.
doi: 10.3341/kjo.2013.27.5.361
Smith MF, Doyle JW, Fanous MM. Modified aqueous drainage implants in the treatment of complicated glaucomas in eyes with pre-existing episcleral bands1. Ophthalmology. 1998;105:2237–42.
doi: 10.1016/S0161-6420(98)91222-2
Smith SL, Starita RJ, Fellman RL, Lynn JR. Early clinical experience with the Baerveldt 350-mm2 glaucoma implant and associated extraocular muscle imbalance. Ophthalmology. 1993;100:914–8.
doi: 10.1016/S0161-6420(93)31554-X
Schwartz KS, Lee RK, Gedde SJ. Glaucoma drainage implants: a critical comparison of types. Curr Opin Ophthalmol. 2006;17:181–9.
doi: 10.1097/01.icu.0000193080.55240.7e
Minckler DS, Vedula SS, Li TJ, Mathew MC, Ayyala RS, Francis BA. Aqueous shunts for glaucoma. Cochrane Database Syst. Rev. 2006:CD004918.
Lloyd MA, Baerveldt G, Fellenbaum PS, Sidoti PA, Minckler DS, Martone JF, et al. Intermediate-term results of a randomized clinical trial of the 350- versus the 500-mm2 Baerveldt implant. Ophthalmology. 1994;101:1456–63. Discussion 63–4.
doi: 10.1016/S0161-6420(94)31152-3
Roy S, Ravinet E, Mermoud A. Baerveldt implant in refractory glaucoma: long-term results and factors influencing outcome. Int Ophthalmol. 2001;24:93–100.
doi: 10.1023/A:1016335313035
Seah SK, Gazzard G, Aung T. Intermediate-term outcome of Baerveldt glaucoma implants in Asian eyes. Ophthalmology. 2003;110:888–94.
doi: 10.1016/S0161-6420(03)00088-5
Sidoti PA, Dunphy TR, Baerveldt G, LaBree L, Minckler DS, Lee PP, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 1995;102:1107–18.
doi: 10.1016/S0161-6420(95)30904-9
Siegner SW, Netland PA, Urban RC Jr, Williams AS, Richards DW, Latina MA, et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology. 1995;102:1298–307.
doi: 10.1016/S0161-6420(95)30871-8
Hwang JM, Kee C. The effect of surface area expansion with pericardial membrane (preclude) in Ahmed glaucoma valve implant surgery. J Glaucoma. 2004;13:335–9.
doi: 10.1097/00061198-200408000-00012
Al-Jazzaf AM, Netland PA, Charles S. Incidence and management of elevated intraocular pressure after silicone oil injection. J Glaucoma. 2005;14:40–6.
doi: 10.1097/01.ijg.0000145811.62095.fa
Dubey S, Prasanth B, Acharya MC, Narula R. Conjunctival erosion after glaucoma drainage device surgery: a feasible option. Indian J Ophthalmol. 2013;61:355–7.
doi: 10.4103/0301-4738.99852
Kiranmaye T, Garudadri CS, Senthil S. Role of oral doxycycline and large diameter bandage contact lens in the management of early post-trabeculectomy bleb leak. BMJ Case Rep. 2014;2014.